Correlation Between Cue Biopharma and Sensei Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Sensei Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Sensei Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Sensei Biotherapeutics, you can compare the effects of market volatilities on Cue Biopharma and Sensei Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Sensei Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Sensei Biotherapeutics.
Diversification Opportunities for Cue Biopharma and Sensei Biotherapeutics
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cue and Sensei is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Sensei Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sensei Biotherapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Sensei Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sensei Biotherapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Sensei Biotherapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Sensei Biotherapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Sensei Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 1.07 times less risky than Sensei Biotherapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Sensei Biotherapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 72.00 in Sensei Biotherapeutics on September 2, 2024 and sell it today you would lose (18.00) from holding Sensei Biotherapeutics or give up 25.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Sensei Biotherapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Sensei Biotherapeutics |
Cue Biopharma and Sensei Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Sensei Biotherapeutics
The main advantage of trading using opposite Cue Biopharma and Sensei Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Sensei Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sensei Biotherapeutics will offset losses from the drop in Sensei Biotherapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Sensei Biotherapeutics vs. Tff Pharmaceuticals | Sensei Biotherapeutics vs. Eliem Therapeutics | Sensei Biotherapeutics vs. Inhibrx | Sensei Biotherapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |